Kristin C. Peck
Chief Executive Officer, Zoetis
Director since
October 2019
Committees
None
Other Current Public Company Directorships
BlackRock (since September 2021)
Ms. Peck brings more than 25 years in business management, including 20-plus years in the health care and animal health industry to the Board. Her deep knowledge of Zoetis, beginning with its initial public offering in 2013, provides an invaluable perspective and critical link between the Board and management team’s execution of strategic growth initiatives. Her strong business experience leading the company as Chief Executive Officer, as well as her history of success in development, implementation and execution of corporate strategy and executive management, make Ms. Peck a qualified and valuable member of the Board.
Skills and Qualifications
Animal Health
Digital and Technology
Global Businesses
Human Capital Management
Life Sciences
Manufacturing and Supply
Marketing and Sales
Mergers and Acquisitions
Other Public Company Board Member
Public Company CEO
Deep expertise in animal health, having paved the way for Zoetis as a public company and defining a global sector. Broad leadership experience spanning Zoetis’ Global Manufacturing and Supply, Global Commercial Development, and its $2.9B U.S. Commercial Business groups.
Extensive experience in finance and innovation across several companies. Since becoming CEO of Zoetis in 2020, Ms. Peck delivered superior financial growth and industry-leading operating margins; launched 18 blockbuster products and established a pipeline of 12 more potential blockbusters (products with expected future potential sales of $100M+).
Strategic and innovative leader with experience in corporate strategy, business development, and digital transformation – including the acceleration of AI adoption and advanced analytics – which has been central to Zoetis’ sustained growth and innovation since its IPO.
Passion and commitment to life sciences and healthcare. Proven leadership in public policy and advocacy as past president of the Animal Health Institute and HealthforAnimals. Currently serves on the Board of Trustees of the Mayo Clinic, a top-ranked global medical center.
Recognized for her transformative leadership in driving Zoetis’ strong performance and innovation, Ms. Peck was named to TIME100 Most Influential People in Health for 2025; included on the CNBC 2024 Changemakers list; selected by Barron’s as one of the top CEOs in 2022 and honored by Fortune as a 2020 Businessperson of the Year. Ms. Peck is a member of the board of directors of Business Roundtable (since January 2026). She previously served as a member of the board of directors of Thomson Reuters.
Career Highlights
Zoetis Inc. (NYSE: ZTS) – a leading global producer of medicine and vaccinations for pets and livestock
- Chief Executive Officer (2020-present)
- Executive Vice President and Group President, U.S. Operations, Business Development and Strategy (2018-2019)
- Executive Vice President and President, U.S. Operations (2015-2018)
Pfizer Inc. (NYSE: PFE) – a global pharmaceutical company
- Executive Vice President, Worldwide Business Development and Innovation (2004-2012)
Education
- Bachelor’s degree from Georgetown University
- Master of Business Administration from Columbia Business School